These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12065542)

  • 1. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.
    Ulett GC; Ketheesan N; Clair TW; McElnea CL; Barnes JL; Hirst RG
    Infect Immun; 2002 Jul; 70(7):3953-8. PubMed ID: 12065542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.
    Ulett GC; Ketheesan N; Hirst RG
    Infect Immun; 2000 Apr; 68(4):2034-42. PubMed ID: 10722599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.
    Barnes JL; Ulett GC; Ketheesan N; Clair T; Summers PM; Hirst RG
    Immunol Cell Biol; 2001 Oct; 79(5):490-501. PubMed ID: 11564157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
    Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
    Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.
    Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK
    PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
    Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
    Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
    Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.
    Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL
    Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
    Barnes JL; Williams NL; Ketheesan N
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.
    Liu B; Koo GC; Yap EH; Chua KL; Gan YH
    Infect Immun; 2002 Feb; 70(2):504-11. PubMed ID: 11796576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
    Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
    J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection.
    Breitbach K; Wongprompitak P; Steinmetz I
    BMC Immunol; 2011 Mar; 12():20. PubMed ID: 21410970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
    Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
    Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.
    Propst KL; Mima T; Choi KH; Dow SW; Schweizer HP
    Infect Immun; 2010 Jul; 78(7):3136-43. PubMed ID: 20404077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
    Wongratanacheewin S; Kespichayawattana W; Intachote P; Pichyangkul S; Sermswan RW; Krieg AM; Sirisinha S
    Infect Immun; 2004 Aug; 72(8):4494-502. PubMed ID: 15271908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.